• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Mertiva AB

DMYDY:US

Ticker Delisted

Snapshot for Mertiva AB (DMYDY)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for DMYDY

No chart data available.
  • DMYDY:US
  • 1M
  • 1Y
0.0000
Interactive DMYDY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DMYDY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 29.58
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.1984
Dividend Ex-Date 06/06/2013
5 Year Dividend Growth -
Next Earnings Announcement 10/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DMYDY

No data available

Company Profile & Key Executives for DMYDY

Mertiva AB develops and markets products for the diagnosis, prevention, and treatment of diabetes. The Company also develops, produces and sells in vitro diagnostic tests for diabetes.Mertiva AB sells its products to the research market worldwide.

Andreas BergstenPresident/CEOAnna StyrudChief Financial Officer
Erika HillborgDirector:Clinical Development
More Company Profile & Key Executives for DMYDY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil